Political Landscape and Its Effect on the Cannabis Sector
The uncertainty surrounding the post-election phase is making investors particularly vigilant in the cannabis sector. Major multi-state operators (MSOs) are caught between potential opportunities and substantial challenges ahead. With the hope of regulatory reform under a new administration, cannabis companies like Verano Holdings (OTC: VRNOF), Green Thumb Industries (OTC: GTBIF), and Gold Flora (OTC: GRAM) are facing a complicated reality of mixed results from recent performance metrics.
Verano Holdings: Navigating Market Challenges
Verano recently reported its Q3 earnings, showing a sales total of $227 million—a 5% decline compared to the previous quarter. This downturn can be attributed to several factors, including seasonal fluctuations and adverse market dynamics in significant states like Florida. The company has recently acquired assets from The Cannabist Company (OTC: CBSTF), but these additions are only expected to partially boost its financial performance. Verano's financial health is under pressure due to a heavy debt load, making up 40% of the last twelve months (LTM) sales, along with considerable tax liabilities reaching 32%.
Profitability Concerns
The adjusted EBITDA margins have seen a reduction of 200 basis points, now resting at 30%. Although market analysts, including Pablo Zuanic, still classify Verano as Overweight, concerns particularly loom over its dependency on the Florida market. Recent election outcomes in Florida, where adult-use legalization was rejected, have had a detrimental impact, as evidenced by a notable 44% drop in Verano's stock value.
Green Thumb Industries: Resilience in the Face of Adversity
In contrast, Green Thumb Industries has shown a more resilient Q3 performance with sales reaching $287 million, marking a 2% increase over the previous quarter. The key to Green Thumb's steadiness lies in its adept cash flow management, which has generated an adjusted operating cash flow of $139 million, translated into 17% of total sales.
Fiscal Strategies and Low Leverage
With net debt at a mere 7% of LTM sales and adjusted EBITDA margins maintained at 31%, Green Thumb appears to maintain a favorable position as it navigates ongoing regulatory challenges. Compared to other players in the field, Green Thumb's financial leverage is significantly lower; Cresco Labs (OTC: CRLBF) carries 80% total liabilities, Curaleaf (OTC: CURLF) follows at 79%, while Verano stands at 72%, compared to Green Thumb’s 9% ratio of LTM sales.
Gold Flora: Strategic Growth in a Challenging Market
Gold Flora continues to advance despite market obstacles, demonstrating notable improvements in its operations during Q3 2024. The company's adjusted gross margins improved phenomenally, rising from 54% in Q1 to an impressive 65% in Q3. Additionally, EBITDA margins reflected progress, climbing to 9% from a low of -6% earlier in the year. The strategic push toward vaping products, especially with their Gramlin line, has received excellent feedback, making it one of the top-10 brands in California.
Financial Stability and Expansion Plans
However, the financial outlook for Gold Flora raises concerns, as its debt obligations have surged to $44 million from $28 million at the end of the previous year. To foster revenue growth, plans are underway for a 50% increase in indoor cultivation capacity and the opening of new retail locations.
Benchmarking Key MSOs: Financial Health Insights
- EBITDA Margins: As of Q3 2024, Trulieve leads with an impressive 34% margin, followed by Green Thumb at 31% and Verano at 30%. Cresco is stable at 29%, with Curaleaf improving to 23%.
- Cash Flow Performance: Green Thumb showcases robust cash flow with an adjusted operating cash flow of $139 million (17% of sales). In comparison, Trulieve and Verano reported $37 million (4%) and $30 million (5%) respectively, while Curaleaf barely broke even at $4 million.
- Valuation Comparisons: Valuation metrics show Green Thumb and Curaleaf trading at an EV-to-sales ratio of 2.2x. Trulieve follows closely at 1.8x, and Cresco and Verano are at 1.6x. For EV-to-EBITDA ratios, Curaleaf is at 10x, with Green Thumb at 7x, while the rest fall to between 5.2x and 5.5x.
Frequently Asked Questions
1. What challenges are cannabis MSOs currently facing?
Cannabis MSOs are grappling with debt, regulatory pressures, and uncertainty in the market, especially after the recent elections.
2. How is Verano Holdings performing financially?
Verano has reported a mixed performance with a decrease in sales and concerns regarding its heavy debt and tax liabilities.
3. Which cannabis company seems to be the most resilient?
Green Thumb Industries shows resilience through strong cash flow management and low leverage, resulting in steady sales growth.
4. What are Gold Flora's plans for future growth?
Gold Flora aims to expand its cultivation capacity by 50% and open new stores to increase revenue despite facing financial instability.
5. How do these companies compare in terms of EBITDA margins?
Trulieve leads with a 34% EBITDA margin, with Green Thumb and Verano at 31% and 30%, respectively, indicating varied profitability levels.
